James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why BRF SA (ADR) (BRFS), Snap Inc (SNAP) and Amgen, Inc. (AMGN) Are 3 of Today’s Worst Stocks

The end of the week couldn't come soon enough for Amgen (AMGN), Snap (SNAP) and BRF SA (BRFS). Here's what you need to know.

Privacy Revamp Makes Facebook Inc (FB) Stock Even More Attractive

Not that Facebook (FB) was held back by its privacy policies, but with that worry abated, Facebook stock is even more of an obvious buy.

Layoffs or Not, GoPro Inc (GPRO) Stock Is Losing an Uphill Battle

GoPro (GPRO) popped 11% on news of cost cuts that could lead it to profitability, but GPRO stock remains in more trouble than it can handle.

A Tesla Inc (TSLA) Cash Raise Gets … A Hero’s Welcome?

Tesla (TSLA) advanced on the news of a secondary offering, but that was no more the right response than a selloff in Tesla stock would have been.

Why Guess?, Inc. (GES), Biogen Inc (BIIB) and Snap Inc (SNAP) Are 3 of Today’s Worst Stocks

Biogen (BIIB), Snap (SNAP) and Guess (GES) were doomed from the start of Thursday's trading, and there was nothing anybody could do about it.